TherAquila

TherAquila Inc. is a Montreal-based preclinical research and drug development management firm that provides specialized operational and strategic oversight for biotech and pharmaceutical companies. Founded in 2011 by industry veterans Dr. Karl-Rudolf Erlemann and Sabrina Torre, the company functions as a "general contractor" for drug development, managing the transition of lead candidates through critical in vivo pharmacology and safety milestones. TherAquila possesses deep expertise in complex modalities, including small molecules, biologics, and RNA/DNA-based immunotherapies, specifically in the fields of oncology and immunology. The firm's collaborative model integrates project management with a global network of specialized CROs and CDMOs to accelerate clinical entry and de-risk development programs.